Cytopharma S.A.

Cytopharma, founded in 2011 in Zaghouan, Tunisia, is the first and only manufacturer in Africa and the Middle East dedicated exclusively to producing and marketing generic injectable cytotoxic drugs for oncology. Portfolio includes Fluorouracil (5-FU), Oxaliplatin, Epirubicin, Paclitaxel, and Docetaxel. Offers distribution, contract manufacturing, co-promotion, and co-marketing partnerships.